R M Chichmanian
- Genetics top 10%
- Blood disorders and treatments 4
- Toxicology top 10%
- Pharmacovigilance and Adverse Drug Reactions 4
-
- Pharmacology and Obesity Treatment 5
- Drug-Induced Adverse Reactions 4
-
- Pharmacological Effects and Toxicity Studies 6
-
- Cancer Treatment and Pharmacology 5
-
- Infectious Diseases and Tuberculosis 4
-
- Metabolism and Genetic Disorders 3
R M Chichmanian
53 papers receiving 474 citations
Peers
Comparison fields: 5 of 77
- Genetics 83
- Toxicology 22
- Infectious Diseases 96
- Pharmacology 86
- Pediatrics, Perinatology and Child Health 89
Countries citing papers authored by R M Chichmanian
This map shows the geographic impact of R M Chichmanian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R M Chichmanian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R M Chichmanian more than expected).
Fields of papers citing papers by R M Chichmanian
This network shows the impact of papers produced by R M Chichmanian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R M Chichmanian. The network helps show where R M Chichmanian may publish in the future.
Co-authorship network
The 25 scholars most cited alongside R M Chichmanian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 45 | |
| 2 | 2008 | 42 | |
| 3 | 2007 | 6 | |
| 4 | 2005 | 11 | |
| 5 | 2004 | 17 | |
| 6 | 2002 | 38 | |
| 7 | 2002 | 19 | |
| 8 | 1999 | 19 | |
| 9 | 1997 | 18 | |
| 10 | 1997 | 16 | |
| 11 | [Economic impact of adverse drug effects. Some reflections]. | 1993 | 5 |
| 12 | [Acute rhabdomyolysis induced by fenoverine. 2 cases]. | 1990 | 1 |
| 13 | 1990 | 1 | |
| 14 | 1989 | 6 | |
| 15 | Accidents systémiques des bêta-bloquants en collyres: A propos de six observations | 1989 | 2 |
| 16 | 1989 | 4 | |
| 17 | [Agranulocytosis caused by paracetamol: a case, with positive readministration]. | 1989 | 3 |
| 18 | Effet de la rifampicine sur la pharmacocinétique de la doxycycline. | 1987 | 4 |
| 19 | Spondylodiscite à Candida albicans. Revue de la littérature à propos d'un cas avec étude de la pénétration osseuse de la 5-fluorocytosine. | 1982 | 2 |
| 20 | [Candida albicans spondylitis. Review of the literature apropos of a case with study of bone penetration of 5-fluorocytosine]. | 1982 | 3 |
About R M Chichmanian
R M Chichmanian is a scholar working on Toxicology, Pharmacology, Emergency Medicine, Pediatrics, Perinatology and Child Health and Infectious Diseases, having authored 53 papers that have together received 498 indexed citations. Recurring topics across this work include Pharmacological Effects and Toxicity Studies (6 papers), Pharmacology and Obesity Treatment (5 papers), Cancer Treatment and Pharmacology (5 papers), Pharmacovigilance and Adverse Drug Reactions (4 papers), Drug-Induced Adverse Reactions (4 papers), Blood disorders and treatments (4 papers), Infectious Diseases and Tuberculosis (4 papers) and Metabolism and Genetic Disorders (3 papers). The work is most often cited by research in Genetics (83 citations), Toxicology (22 citations), Infectious Diseases (96 citations), Pharmacology (86 citations) and Pediatrics, Perinatology and Child Health (89 citations). R M Chichmanian has collaborated with scholars based in France, Netherlands and Bulgaria. Frequent co-authors include P. Thomas, V. Bourg, Christine Lebrun‐Frénay, Marc Frénay, P. Dellamonica, Christine Katlama, Dominique Costagliola, V. Mondain, Jean‐Philippe Spano and R. Garraffo. Their work appears in journals such as Clinical Microbiology and Infection, Gut, Antimicrobial Agents and Chemotherapy, Annals of Oncology and European Journal of Clinical Microbiology & Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.